Literature DB >> 28325222

Effects of ultra-high dilutions of sodium butyrate on viability and gene expression in HEK 293 cells.

Steven Olsen1.   

Abstract

BACKGROUND: Several recent studies reported the capability of high diluted homeopathic medicines to modulate gene expression in cell cultures. In line with these studies, we examined whether ultra-high dilutions (30C and 200C) of sodium butyrate (SB) can affect the expression levels of genes involved in acquisition of a senescence-associated secretory phenotype (SASP) in human embryonic kidney (HEK) 293 cells.
METHODS: Cell viability was evaluated using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. The expression levels of TNF-α, interleukin (IL)-2, IL-4, IL-6 and IL-10 genes were determined by real-time PCR assay.
RESULTS: Exposure to both 30C and 200C during 48 h led to a significant decrease of the level of expression of TNF-α gene, while expression of IL-2 gene was increased when exposed to 30C, and expression of IL-10 gene was decreased when exposed to 200C. No changes in expression levels of all genes studied were observed in cells treated with both 30C and 200C remedies of SB during the 24 h.
CONCLUSION: Observed changes in gene expression levels after exposure to 30C and 200C remedies of SB during 48 h suggest that extremely low concentrations of this agent can modulate the transcriptome of HEK 293 cells. These results are in line with findings from other studies confirming the ability of homeopathic remedies to modulate gene expression in cell cultures.
Copyright © 2017 The Faculty of Homeopathy. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene expression; HEK 293 cells; Sodium butyrate; Ultra-high dilutions

Mesh:

Substances:

Year:  2017        PMID: 28325222     DOI: 10.1016/j.homp.2017.01.003

Source DB:  PubMed          Journal:  Homeopathy        ISSN: 1475-4916            Impact factor:   1.444


  1 in total

Review 1.  Exploring Possible Mechanisms of Hormesis and Homeopathy in the Light of Nanopharmacology and Ultra-High Dilutions.

Authors:  Dana Ullman
Journal:  Dose Response       Date:  2021-06-14       Impact factor: 2.658

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.